Accrued expenses consisted of the following (in thousands):
As ofJune 30, 2026
As ofDecember 31,2025
Accrued research and development expenses
$
7,938
8,297
Other
1,256
134
Total accrued expenses
9,194
8,431
Tabular disclosure of the components of accrued liabilities.
No definition available.